<DOC>
	<DOCNO>NCT03057756</DOCNO>
	<brief_summary>The principal objective evaluate cure rate number adverse event confirm multidrug-resistant tuberculosis patient treat 9months regimen .</brief_summary>
	<brief_title>Treatment Tuberculosis Multidrug Resistance Treatment Tuberculosis Multidrug Resistance</brief_title>
	<detailed_description>Study participant follow , exist protocol derive study protocol develop `` Union internationale contre les malady respiratoires '' carry already 9 Africans country . Participants hospitalise least four month , period give treatment , assessed adverse event , monitor TB-MR strain use culture technique , monthly basis . If patient find negative sputum culture month four dischrged hospital , treat four additional five montns follow , clinically biologically additional six month declare cure .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Multidrug-Resistant</mesh_term>
	<criteria>Inclusion criterion : Aged 15 year Never treat second line antiTB drug one month , Give write consent participate Agree hospitalise least four month specialise healthcare Willing adhere ambulatory directly observe treatment healthcare worker ; Exclusion criterion : Pregnant inclusion process Presented altered clinical status condition judge clinician Knowing history hypersensitivity reaction drug use Baseline ECG show QT space superior 500ms Refusal participate study .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Multi-drug Resistant Tuberculosis</keyword>
	<keyword>short course regimen protocol</keyword>
</DOC>